A systems biology analysis of autophagy in cancer therapy

Zheng Shi1, Chun-yang Li, Si Zhao

  • 1School of Life Sciences and Key Laboratory of Bio-Resources, Ministry of Education, Sichuan University, Chengdu 610064, China; School of Life Sciences, Guizhou Normal University, Guiyang 550001, China.

Cancer Letters
|June 25, 2013
PubMed

Insights

Autophagy, a cellular degradation process, plays a complex role in cancer. Understanding its intricate network through systems biology can improve cancer therapies and drug discovery.

Area of Science:

  • Cellular Biology
  • Oncology
  • Systems Biology

Background:

  • Autophagy, the process of degrading cellular components, is closely linked to human diseases, particularly cancer.
  • Autophagy influences cancer initiation and progression due to overlapping signaling pathways.
  • Cancer's complexity as a systemic disease involves multiple signaling pathways beyond autophagy.

Purpose of the Study:

  • To propose a systems biology approach for analyzing the autophagy-cancer network.
  • To focus on systems biology analysis for understanding autophagy in cancer therapy.
  • To enhance comprehension of autophagy-cancer relationships and aid cancer drug discovery.

Main Methods:

  • Review of existing literature on autophagy and cancer signaling.
  • Application of systems biology principles to analyze the autophagy-cancer network.
  • Focus on inter-connectivity and cross-talk pathways within the autophagy-cancer system.

Main Results:

  • The review highlights the intricate and multifaceted role of autophagy in cancer.
  • It emphasizes the need for a systems-level understanding of autophagy-cancer interactions.
  • The proposed perspective facilitates the identification of novel therapeutic targets.

Conclusions:

  • A systems biology perspective is crucial for a comprehensive analysis of the autophagy-cancer network.
  • This approach can significantly improve our understanding of autophagy's role in cancer.
  • It holds promise for advancing cancer drug discovery and therapeutic strategies.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...